Citadel Advisors - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 18 filers reported holding PROTEON THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$19,000
+11.8%
46,960
+11.8%
0.00%
Q2 2019$17,000
-62.2%
42,020
+132.4%
0.00%
Q1 2018$45,000
+104.5%
18,079
+45.0%
0.00%
Q1 2017$22,00012,4670.00%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Deer VII & Co. Ltd. 315,101$599,00025.51%
Abingworth LLP 2,017,872$3,632,0003.04%
Pharmstandard International S.A. 1,165,344$2,214,0001.91%
MPM ASSET MANAGEMENT LLC 983,381$1,868,0000.88%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,332,599$2,532,0000.10%
Perceptive Advisors 334,116$635,0000.04%
Baker Brothers Advisors 389,394$740,0000.01%
WEDBUSH SECURITIES INC 17,000$32,0000.01%
FINANCIAL COUNSELORS INC 50,000$95,0000.01%
PILLAR PACIFIC CAPITAL MANAGEMENT LLC 11,499$21,0000.00%
View complete list of PROTEON THERAPEUTICS INC shareholders